According to all experimental results, CLTCL1, MTM1, and MLH1 are likely tumor suppressor genes exerting inhibitory effects on osteosarcoma development, while SQLE and EDIL3 may function as targets promoting tumor proliferation, thus presenting new therapeutic potential. This evidence concerns the gene CLTCL1 and osteosarcoma.